Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,090 hedge funds and large institutions have $56B invested in Allergan plc in 2017 Q3 according to their latest regulatory filings, with 95 funds opening new positions, 475 increasing their positions, 390 reducing their positions, and 110 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 475 | Existing positions reduced: 390
2% less funds holding
Funds holding: 1,115 → 1,090 (-25)
14% less first-time investments, than exits
New positions opened: 95 | Existing positions closed: 110
17% less capital invested
Capital invested by funds: $67.3B → $56B (-$11.4B)
33% less funds holding in top 10
Funds holding in top 10: 73 → 49 (-24)
38% less call options, than puts
Call options by funds: $1.57B | Put options by funds: $2.51B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$214M |
| 2 |
Edgewood Management
Greenwich,
Connecticut
|
+$202M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$138M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$131M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$129M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
-$378M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$330M |
| 3 |
Goldman Sachs
New York
|
-$299M |
| 4 |
Jennison Associates
New York
|
-$289M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$253M |
AGN Hedge Fund Activity: Q3 2017 in Review
1,090 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2017, worth a combined $56B — down 17% from $67.3B a quarter earlier.
Sellers outnumbered buyers: 110 funds closed out of AGN and 95 opened new positions — a net loss of 15 holders — while 390 trimmed existing stakes and 475 added.
The largest buyer was Susquehanna International Group, adding an estimated $214M. The largest seller was Parnassus Investments, cutting an estimated $378M.
- 1,090 institutional investors held Allergan plc (AGN) as of Q3 2017, down from 1,115 in Q2 2017.
- Funds reported $56B of Allergan plc stock for Q3 2017, down 17% quarter-over-quarter.
- 95 funds opened new Allergan plc positions in Q3 2017 and 110 closed out, a net change of -15 holders.
- The largest Allergan plc buyer in Q3 2017 was Susquehanna International Group, an estimated $214M added.
- The largest Allergan plc seller in Q3 2017 was Parnassus Investments, an estimated $378M sold.
Based on aggregated 13F filings for Q3 2017.